Vericel Corp (VCEL) financials

NASDAQ · Health Care

$40.26 -6.18% Close Oct 30, 2026 Live

Vericel revenue and earnings by year

Vericel's revenue was $276 million in the fiscal year to December 31, 2025, up 16.5% from the year before. Net income was $16.5 million, 6.0% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 19.8% a year on average.

RevenueNet income
$0$100M$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue276237198164156124118916454
Revenue growth16.5%20.1%20.2%5.2%25.8%5.4%29.7%42.1%17.5%—
Gross profit2061721361101068480593426
Gross margin74.4%72.6%68.6%66.8%67.9%67.8%68.1%64.6%52.5%47.9%
Operating income115-6-17-82-11-4-15-19
Operating margin4.0%1.9%-3.3%-10.4%-5.0%1.9%-9.5%-4.3%-23.4%-35.4%
Net income1710-3-17-73-10-8-17-20
Net margin6.0%4.4%-1.6%-10.2%-4.8%2.3%-8.2%-9.0%-27.0%-36.0%
Diluted EPS$0.32$0.20-$0.07-$0.35-$0.16$0.05-$0.25-$0.24-$0.52—
Free cash flow25-615102115-10-3-15-21

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open VCEL in Markets.

See also: VCEL valuation and P/E history · VCEL returns

No forecast, no recommendation. This page describes Vericel Corp from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.